These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1975486)

  • 1. Myopathy with human immunodeficiency virus type 1 (HIV-1) infection: HIV-1 or zidovudine?
    Till M; MacDonell KB
    Ann Intern Med; 1990 Oct; 113(7):492-4. PubMed ID: 1975486
    [No Abstract]   [Full Text] [Related]  

  • 2. [Muscular involvement in human immunodeficiency virus infection].
    Laraki R; Lebas J; Baudrimont M; Cabane J; Giral P; Wattiaux MJ; Picard O; Imbert JC
    Ann Med Interne (Paris); 1990; 141(2):187-92. PubMed ID: 2191617
    [No Abstract]   [Full Text] [Related]  

  • 3. HIV or zidovudine myopathy?
    Kieburtz K
    Neurology; 1994 Feb; 44(2):361; author reply 362-4. PubMed ID: 8309596
    [No Abstract]   [Full Text] [Related]  

  • 4. [Muscular involvement in HIV infection].
    Gherardi R; Chariot P; Authier FJ
    Rev Neurol (Paris); 1995 Nov; 151(11):603-7. PubMed ID: 8745623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skeletal muscle involvement in HIV-infected patients.
    Gherardi RK
    Neuropathol Appl Neurobiol; 1994 Jun; 20(3):232-7. PubMed ID: 7936072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Muscular complications in HIV infection].
    Authier FJ; Chariot P; Gherardi R
    Arch Anat Cytol Pathol; 1997; 45(2-3):174-8. PubMed ID: 9382610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV or zidovudine myopathy?
    Gherardi R; Chariot P
    Neurology; 1994 Feb; 44(2):361-2; author reply 362-4. PubMed ID: 8309597
    [No Abstract]   [Full Text] [Related]  

  • 8. Concurrent zidovudine-induced myopathy and hepatoxicity in patients treated for human immunodeficiency virus (HIV) infection.
    Chen SC; Barker SM; Mitchell DH; Stevens SM; O'Neill P; Cunningham AL
    Pathology; 1992 Apr; 24(2):109-11. PubMed ID: 1641255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognosis in AZT myopathy.
    Chalmers AC; Greco CM; Miller RG
    Neurology; 1991 Aug; 41(8):1181-4. PubMed ID: 1714057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial abnormalities in human immunodeficiency virus-associated myopathy.
    Morgello S; Wolfe D; Godfrey E; Feinstein R; Tagliati M; Simpson DM
    Acta Neuropathol; 1995; 90(4):366-74. PubMed ID: 8546027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zidovudine therapy and myopathies associated with human immunodeficiency virus infection.
    Chariot P; Ruet E; Gherardi R
    Ann Neurol; 1994 Feb; 35(2):247-8. PubMed ID: 8109910
    [No Abstract]   [Full Text] [Related]  

  • 12. The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group.
    Fischl MA; Richman DD; Hansen N; Collier AC; Carey JT; Para MF; Hardy WD; Dolin R; Powderly WG; Allan JD
    Ann Intern Med; 1990 May; 112(10):727-37. PubMed ID: 1970466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zidovudine myopathy: a distinctive disorder associated with mitochondrial dysfunction.
    Mhiri C; Baudrimont M; Bonne G; Geny C; Degoul F; Marsac C; Roullet E; Gherardi R
    Ann Neurol; 1991 Jun; 29(6):606-14. PubMed ID: 1892364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myopathies associated with human immunodeficiency virus and zidovudine: can their effects be distinguished?
    Simpson DM; Citak KA; Godfrey E; Godbold J; Wolfe DE
    Neurology; 1993 May; 43(5):971-6. PubMed ID: 8492955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial myopathy caused by long-term zidovudine therapy.
    Dalakas MC; Illa I; Pezeshkpour GH; Laukaitis JP; Cohen B; Griffin JL
    N Engl J Med; 1990 Apr; 322(16):1098-105. PubMed ID: 2320079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myopathy in human immunodeficiency virus-infected children receiving long-term zidovudine therapy.
    Walter EB; Drucker RP; McKinney RE; Wilfert CM
    J Pediatr; 1991 Jul; 119(1 Pt 1):152-5. PubMed ID: 1906098
    [No Abstract]   [Full Text] [Related]  

  • 17. HIV or zidovudine myopathy?
    Dalakas M
    Neurology; 1994 Feb; 44(2):360-1; author reply 362-4. PubMed ID: 8309594
    [No Abstract]   [Full Text] [Related]  

  • 18. Characteristics and pathogenesis of myositis in human immunodeficiency virus infection--distinction from azidothymidine-induced myopathy.
    Espinoza LR; Aguilar JL; Espinoza CG; Gresh J; Jara J; Silveira LH; Martinez-Osuna P; Seleznick M
    Rheum Dis Clin North Am; 1991 Feb; 17(1):117-29. PubMed ID: 2041882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myopathy associated with human immunodeficiency virus (HIV) but not with zidovudine.
    Simpson DM
    Ann Intern Med; 1988 Nov; 109(10):842. PubMed ID: 3190033
    [No Abstract]   [Full Text] [Related]  

  • 20. Myopathy in HIV infection: the role of zidovudine and the significance of tubuloreticular inclusions.
    Lane RJ; McLean KA; Moss J; Woodrow DF
    Neuropathol Appl Neurobiol; 1993 Oct; 19(5):406-13. PubMed ID: 8278024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.